| Literature DB >> 28094937 |
Nathan S Abell1, Marvin Mercado1, Tatiana Cañeque2,3,4,5, Raphaël Rodriguez2,3,4,5, Blerta Xhemalce1.
Abstract
Enoxacin is a small molecule that stimulates RNA interference (RNAi) and acts as a growth inhibitor selectively in cancer but not in untransformed cells. Here, we used alkenox, a clickable enoxacin surrogate, coupled with quantitative mass spectrometry, to identify PIWIL3 as a mechanistic target of enoxacin. PIWIL3 is an Argonaute protein of the PIWI subfamily that is mainly expressed in the germline and that mediates RNAi through piRNAs. Our results suggest that cancer cells re-express PIWIL3 to repress RNAi through miRNAs and thus open a new opportunity for cancer-specific targeting.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28094937 DOI: 10.1021/jacs.6b11751
Source DB: PubMed Journal: J Am Chem Soc ISSN: 0002-7863 Impact factor: 15.419